Catalyst Pharmaceuticals completes acquisition by Angelini Pharma, delisting from Nasdaq
Catalyst Pharmaceuticals completed its acquisition by Angelini Pharma and Angelini Cielo Inc. on July 15, 2026, becoming a wholly owned subsidiary of the…
Company
SEC filing news and material events for CATALYST PHARMACEUTICALS, INC., briefed from primary-source filings.
1 story
Catalyst Pharmaceuticals completed its acquisition by Angelini Pharma and Angelini Cielo Inc. on July 15, 2026, becoming a wholly owned subsidiary of the…